NewsBenzinga뉴로센스 테라퓨틱스, 상반기 주당순손실 2.10달러···전년 대비 3.70달러 개선 뉴로센스 테라퓨틱스, 상반기 주당순손실 2.10달러···전년 대비 3.70달러 개선 Benzinga 2026.09.25 20:33 (GMT+0) Open on Benzinga Other news Amazon founder Bezos says AI could let Americans support a family working just three days a week Undercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And More Tibo: OpenAI Dots May Come to the EU in the Future Whale closes $110M BTC long, then opens $45.8M long on US stocks Meta: Dense Access by Claude-Related Tools Triggered Security System, Causing Instagram Account to Be Wrongly Banned Nscale's ~$30 Billion IPO Valuation Target Questioned, Some Investors Advocate $16–19 Billion
Meta: Dense Access by Claude-Related Tools Triggered Security System, Causing Instagram Account to Be Wrongly Banned
